This is the first update to the original CTS communication distributed on July 6th. As previously communicated, all CTS healthcare partners will remain on the Grifols ZIKV clinical trial until at least the end of October 2018, which coincides with the end of the WNV season.
Check out the Communication page for the complete details on the NAT ZIKV test update or by clicking the link: Communications
As winter weather continues to move through parts of the US, we would like to remind you it may be n...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
CTS will be revising some forms in use by clients on October 26, 2020. We do try to limit form chang...
Beginning June 1, 2020 all 5 CTS laboratories will being transitioning from the Grifols Procleix Ult...
FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screen...
Josh Moon has been appointed Chief Operating Officer (COO) at Creative Testing Solutions (CTS), effe...